Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 11/05/20
Aldeyra to Participate in the American Academy of Ophthalmology Eyecelerator 2020 Virtual Conference on Friday, November 6Business Wire • 11/04/20
Aldeyra Has 'Catalayst-Rich' 12 Months Ahead, Jefferies Says In Bullish InitiationBenzinga • 10/31/20
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third-Quarter 2020 Financial Results and Corporate UpdateBusiness Wire • 10/29/20
Aldeyra to Present New Reproxalap Data from Phase 2 Clinical Trial in Allergic Conjunctivitis at American Academy of Ophthalmology 2020 Annual MeetingBusiness Wire • 10/22/20
Has Aldeyra Therapeutics (ALDX) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 10/02/20
Aldeyra to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech SummitBusiness Wire • 09/16/20
Aldeyra to Present at Cantor and H.C. Wainwright Virtual Investor ConferencesBusiness Wire • 09/10/20
Aldeyra Receives Study May Proceed Letter from FDA to Initiate Clinical Trial of ADX-629 in COVID-19 PatientsBusiness Wire • 09/09/20
Aldeyra Therapeutics, Inc. (ALDX) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 08/12/20
Aldeyra Therapeutics, Inc. (ALDX) CEO Todd Brady on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Aldeyra Therapeutics Announces Second-Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 08/06/20
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second-Quarter 2020 Financial Results and Corporate UpdateBusiness Wire • 07/30/20
Aldeyra Therapeutics Announces Stock Sales to Perceptive Advisors and Avidity PartnersBusiness Wire • 07/14/20
Aldeyra Therapeutics to Present at the OIS Virtual Public Company Showcase on July 16, 2020Business Wire • 07/13/20
Aldeyra Therapeutics Announces New Drug Application (NDA) Development Plans for Dry Eye DiseaseBusiness Wire • 07/07/20
What Makes Aldeyra Therapeutics, Inc. (ALDX) a New Strong Buy StockZacks Investment Research • 06/22/20
Aldeyra's Reproxalap Progress And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 06/07/20